West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research
西弗吉尼亚临床和转化科学研究所:通过合作伙伴关系和变革性研究改善健康
基本信息
- 批准号:10435710
- 负责人:
- 金额:$ 367.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAppalachian RegionAreaArtificial IntelligenceAutomobile DrivingAwardBackBig DataCOVID-19COVID-19 pandemicCOVID-19 patientCenter for Translational Science ActivitiesCessation of lifeClinicalClinical ResearchClinical SciencesCollaborationsColorCommunicationCommunication ResearchCommunitiesDataData SetDevelopmentDistrict HospitalsElectronic Health RecordEnsureFamilyFoundationsFundingGoalsHealthHispanicsIndividualInfrastructureInstitutesLeadershipMachine LearningManuscriptsMedical centerMinorityMinority GroupsNational Institute of General Medical SciencesNative AmericansNetwork InfrastructureNew EnglandNorth DakotaPatient-Focused OutcomesPediatric HospitalsPersonsPopulationProductivityPuerto RicoResearchResearch PersonnelRuralRural PopulationSARS-CoV-2 infectionScienceSiteStimulusStructureTechniquesTraining and EducationTranslational ResearchUnderserved PopulationUnited StatesUnited States National Institutes of HealthUniversitiesVermontWest VirginiaWorkaging populationcohortcomorbiditycoronavirus diseasedata resourcedata submissionexperienceimprovedinvestigator trainingmortalitynovel coronavirusoperationprogramsresearch study
项目摘要
Since the emergence of the novel coronavirus (SARS-Cov-2) in the United States, more than 33
million cases have been confirmed, and the death toll has climbed to over 600,000 persons. The
Institutional Development Award Program (IDeA) Clinical and Translational Research Centers
(CTRs) are located in diverse areas of the US, serving rural populations as well as other
underserved groups, including Native Americans, Hispanic individuals, and persons of color.
Many states served by IDeA-CTRs have been among those hardest hit by the COVID-19
pandemic. The National COVID Cohort Collaborative (N3C) has been established by the National
Center for Data to Health (CD2H) in partnership with the National Center for Advancing
Translational Sciences (NCATS) as a centralized national data resource for the study of COVID-
19. Over the past year, the 8 IDeA-CTRs participating in National COVID Cohort Collaborative
(N3C) have contributed electronic health record (EHR) data on more than 175,000 individuals
infected with SARS-COV-2. IDeA-CTR investigators have led multiple N3C Domain Teams,
participated in many data projects, and engaged more than 150 IDeA state investigators across
the US. Moreover, N3C has served as a stimulus for the IDeA CTRs to work as a highly
collaborative network. IDeA CTRs are now well poised to build on this experience to enable
inclusion of EHRs from additional areas of the United States, broaden engagement of diverse
investigators throughout IDeA states, and most importantly, to drive science relevant to minority
and underserved IDeA state populations with communication of results to those communities. We
will accomplish these broad objectives through the following aims: Aim 1 - Build IDeA-CTR
infrastructure to organize collaboration among IDeA CTRs for purposes of driving relevant
science; AIM 2 - Expand IDeA-CTR data contributions to N3C, thereby, increasing representation
of minority, rural, and other underserved populations in the N3C dataset; Aim 3 - Provide the
necessary analytic support to conduct cutting-edge big data research using a range of techniques,
including machine learning (ML) and artificial intelligence (AI), to answer important research
questions regarding impact of SARS-CoV-2 in IDeA states; and Aim 4 - Actively engage
investigators in IDeA states to enable conduct of high quality COVID-19 data projects (through
N3C) relevant to populations in their respective states while facilitating investigator development.
自从美国出现新颖的冠状病毒(SARS-COV-2)以来,超过33
已经确认了百万案件,死亡人数已攀升至60万人。这
机构发展奖计划(IDEA)临床和转化研究中心
(CTR)位于美国的不同地区,服务于农村人口以及其他地区
服务不足的团体,包括美洲原住民,西班牙裔人和有色人种。
IDEA-CTR服务的许多州一直是Covid-19的最艰难的人之一
大流行。国家共同队列合作(N3C)已由国家建立
卫生数据中心(CD2H)与国家前进中心合作
转化科学(NCAT)作为研究研究的集中式国家数据资源
19。在过去的一年中,参加国家共同队列合作的8个Idea-ctrs
(N3C)对超过175,000个人贡献了电子健康记录(EHR)数据
感染SARS-COV-2。 Idea-CTR调查人员领导了多个N3C域团队,
参加了许多数据项目,并参与了150多名IDEA州调查员
美国。此外,N3C还刺激了CTR的想法
协作网络。 IDEA CTR现在已经准备好以这种体验为基础来启用
包括来自美国其他领域的EHR,扩大了不同的参与
整个思想状态的调查人员,最重要的是,推动科学与少数群体相关的科学
以及服务不足的思想国家人口与这些社区的结果交流。我们
将通过以下目的实现这些广泛的目标:目标1-构建Idea -CTR
为了驾驶相关目的,基础架构组织CTR之间的协作
科学; AIM 2-将IDEA -CTR数据贡献扩展到N3C,从而增加表示形式
N3C数据集中的少数民族,农村和其他服务不足的人群;目标3-提供
必要的分析支持,以使用一系列技术进行尖端的大数据研究,
包括机器学习(ML)和人工智能(AI),以回答重要的研究
关于SARS-COV-2在思想状态中的影响的问题;目标4-积极参与
思想状态的调查人员能够实现高质量的Covid-19数据项目(通过
N3C)与各自州的人口有关,同时促进研究人员的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sally Lynn Hodder其他文献
Sally Lynn Hodder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sally Lynn Hodder', 18)}}的其他基金
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 367.28万 - 项目类别:
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
西弗吉尼亚州临床和转化科学研究所:全州范围内的组织,致力于打造卓越研究并吸引社区改善健康
- 批准号:
10685808 - 财政年份:2012
- 资助金额:
$ 367.28万 - 项目类别:
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
西弗吉尼亚州临床和转化科学研究所:全州范围内的组织,致力于打造卓越研究并吸引社区改善健康
- 批准号:
10876541 - 财政年份:2012
- 资助金额:
$ 367.28万 - 项目类别:
West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research
西弗吉尼亚临床和转化科学研究所:通过合作伙伴关系和变革性研究改善健康
- 批准号:
10213751 - 财政年份:2012
- 资助金额:
$ 367.28万 - 项目类别:
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
西弗吉尼亚州临床和转化科学研究所:全州范围内的组织,致力于打造卓越研究并吸引社区改善健康
- 批准号:
10842070 - 财政年份:2012
- 资助金额:
$ 367.28万 - 项目类别:
Driving Cutting Edge Clinical Trial Enrollment in Rural Populations: West Virginia's Mobile Clinical Trials Unit
推动农村人口的尖端临床试验注册:西弗吉尼亚州的移动临床试验单位
- 批准号:
10400301 - 财政年份:2012
- 资助金额:
$ 367.28万 - 项目类别:
Alterations and Renovations for Clinical Research Resources and Facilities
临床研究资源和设施的改造和翻新
- 批准号:
10505672 - 财政年份:2012
- 资助金额:
$ 367.28万 - 项目类别:
West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research
西弗吉尼亚临床和转化科学研究所:通过合作伙伴关系和变革性研究改善健康
- 批准号:
10293104 - 财政年份:2012
- 资助金额:
$ 367.28万 - 项目类别:
相似海外基金
AppalTRuST Project 2: Exposure to tobacco marketing for novel tobacco products and associations with future tobacco use in Appalachian young adults: tobacco regulatory science implications
AppalTrust 项目 2:接触新型烟草产品的烟草营销以及与阿巴拉契亚年轻人未来烟草使用的关联:烟草监管科学影响
- 批准号:
10665321 - 财政年份:2023
- 资助金额:
$ 367.28万 - 项目类别:
Appalachian Tobacco Regulatory Science Team (AppalTRuST)
阿巴拉契亚烟草监管科学团队 (AppalTRuST)
- 批准号:
10665319 - 财政年份:2023
- 资助金额:
$ 367.28万 - 项目类别:
AHCRA: Access to Health Care in Rural Appalachia
AHCRA:阿巴拉契亚农村地区获得医疗保健的机会
- 批准号:
10790520 - 财政年份:2023
- 资助金额:
$ 367.28万 - 项目类别:
Investigation of Sex and Gender Differences in Cardiovascular Risk in Rural Communities
农村社区心血管风险的性别和性别差异调查
- 批准号:
10608716 - 财政年份:2023
- 资助金额:
$ 367.28万 - 项目类别: